Replimune Group, Inc. (REPL)
8.17
-0.06
(-0.73%)
USD |
NASDAQ |
Jan 09, 14:16
Replimune Group Accounts Payable (Quarterly): 6.404M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Rapt Therapeutics, Inc. | 2.102M |
| Olema Pharmaceuticals, Inc. | 3.474M |
| CorMedix, Inc. | 20.45M |
| Verastem, Inc. | 9.888M |
| Anavex Life Sciences Corp. | 4.249M |